Sagility Reports Strong FY26 Results; Recommends Final Dividend and New Stock Scheme

Sagility Reports Strong FY26 Results; Recommends Final Dividend and New Stock Scheme​

Sagility Limited, a leading provider of technology-enabled business solutions to the U.S. healthcare industry, announced its consolidated financial results for the quarter and full fiscal year (FY26) ended March 31, 2026, on May 12, 2026. The company reported strong year-over-year growth metrics across its operations.

At its Board of Directors meeting held on May 12, 2026, the Board approved the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026, and received an unmodified opinion from the Statutory Auditors on the financial performance.

Financial Performance Highlights​

For the full fiscal year ended March 31, 2026, Sagility recorded total revenue of ₹ 71,929 million, marking a Year-over-Year (YoY) growth of 29.1% (or 23.6% in constant currency terms) over the previous fiscal year.

Key financial metrics for FY26 included:

• Revenue: ₹ 71,929 million, up 29.1% YoY.
• Adjusted EBITDA: Reached ₹ 18,200 million, achieving 25.1% of revenue, representing a 23.9% growth over FY25.
• Adjusted Profit After Tax (PAT): Was ₹ 11,306 million, equating to 15.7% of revenue, which is a 39.5% YoY growth.
• Basic Earnings per share (EPS): Stood at ₹ 1.98, reflecting a 69.2% YoY growth.

The financial highlights for the quarter ended March 31, 2026, reported a revenue of ₹ 20,243 million, showing a YoY growth of 29.1% (22.2% in CC terms). Adjusted EBITDA for the quarter was ₹ 5,036 million, translating to 24.9% of revenue, and Adjusted PAT was ₹ 3,069 million.

Corporate Actions and Recommendations​

The Board of Directors also made key recommendations to the shareholders:

• Final Dividend: The Board recommended a final dividend of ₹ 0.10 per Equity share, corresponding to a face value of ₹ 10 per share, for the financial year ended March 31, 2026. This recommendation is subject to the approval of the shareholders at the ensuing Annual General Meeting (AGM).
• Employee Stock Options Scheme: The Board approved the 'Sagility Limited - Employee Stock Options and Performance Stock Units Scheme 2026' (ESOS 2026). This scheme, recommended by the Nomination and Remuneration Committee, is designed for granting stock options to eligible Directors and employees of the Company and its subsidiaries, and is also subject to shareholder approval.

Operational and Market Status​

Operationally, Sagility reported securing $30.7 million of potential steady-state Annual Contract Value (ACV) through new business wins and expansion under existing Statements of Work (SOW). The company continued its strategic focus on advancing AI orchestration through its SmarTec and Synchrony suite of solutions, positioning itself as a technology and AI-led healthcare operations transformation partner. As of March 31, 2026, the company reported a presence in 5 countries with 31 delivery centers.

Financial Statement Overview​

The company provided consolidated financial results, which show significant growth in its asset base and equity.

Consolidated Balance Sheet (₹ in millions)


The Consolidated Statement of Cash Flows details cash generated from operating activities for the year ended March 31, 2026, standing at ₹ 15,764.68 million, compared to ₹ 13,874.31 million in the previous year.

Consolidated Financial Results (₹ million)

SAGILITY Stock Price Movement​

Shares of SAGILITY LIMITED today slipped by 3.69% to settle at ₹43.09, marking a downturn for the IT-focused stock. The equity saw substantial trading volume, logging an estimated 24.69 million shares throughout the session.